TMO
Thermo Fisher Scientific Inc.
NYSE · Healthcare · Medical - Diagnostics & Research · US
$608.30
−1.64%Margins
Gross margin
40.4%
EBITDA margin
23.6%
EBIT margin
17.7%
Net margin
15.1%
FCF margin
15.8%
13.2%
Return on equity
6.2%
Return on assets
8.6%
Return on invested capital
0.41x
Asset turnover
$9.0B
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026